These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 18281504)
21. Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity. Maimone MM; Tollefsen DM J Biol Chem; 1990 Oct; 265(30):18263-71. PubMed ID: 2211700 [TBL] [Abstract][Full Text] [Related]
22. Activation of heparin cofactor II by dermatan sulfate. Tollefsen DM; Pestka CA; Monafo WJ J Biol Chem; 1983 Jun; 258(11):6713-6. PubMed ID: 6687888 [TBL] [Abstract][Full Text] [Related]
23. Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases. Langford-Smith KJ; Mercer J; Petty J; Tylee K; Church H; Roberts J; Moss G; Jones S; Wynn R; Wraith JE; Bigger BW J Inherit Metab Dis; 2011 Apr; 34(2):499-508. PubMed ID: 21170681 [TBL] [Abstract][Full Text] [Related]
24. Glycosaminoglycan-binding properties and kinetic characterization of human heparin cofactor II expressed in Escherichia coli. Sarilla S; Habib SY; Tollefsen DM; Friedman DB; Arnett DR; Verhamme IM Anal Biochem; 2010 Nov; 406(2):166-75. PubMed ID: 20670608 [TBL] [Abstract][Full Text] [Related]
25. The interaction of glycosaminoglycans with heparin cofactor II. Tollefsen DM Ann N Y Acad Sci; 1994 Apr; 714():21-31. PubMed ID: 8017769 [TBL] [Abstract][Full Text] [Related]
26. Modulation of heparin cofactor II activity by glycosaminoglycans and adhesive glycoproteins. Petzelbauer E; Seiffert D; Beckmann R; Pusch B; Geiger M; Binder BR Thromb Res; 1992 Jun; 66(5):559-67. PubMed ID: 1381850 [TBL] [Abstract][Full Text] [Related]
27. Contribution of basic residues of the A helix of heparin cofactor II to heparin- or dermatan sulfate-mediated thrombin inhibition. Hayakawa Y; Hirashima Y; Kurimoto M; Hayashi N; Hamada H; Kuwayama N; Endo S FEBS Lett; 2002 Jul; 522(1-3):147-50. PubMed ID: 12095635 [TBL] [Abstract][Full Text] [Related]
28. Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonist. Buchanan MR; Brister SJ Thromb Res; 2000 Sep; 99(6):603-12. PubMed ID: 10974347 [TBL] [Abstract][Full Text] [Related]
29. Altered dermatan sulfate structure and reduced heparin cofactor II-stimulating activity of biglycan and decorin from human atherosclerotic plaque. Shirk RA; Parthasarathy N; San Antonio JD; Church FC; Wagner WD J Biol Chem; 2000 Jun; 275(24):18085-92. PubMed ID: 10749870 [TBL] [Abstract][Full Text] [Related]
30. Immobilization of dermatan sulphate on a silica matrix and its possible use as an affinity chromatography support for heparin cofactor II purification. Sinniger V; Tapon-Bretaudière J; Zhou FL; Bros A; Muller D; Jozefonvicz J; Fischer AM J Chromatogr; 1991 Feb; 539(2):289-96. PubMed ID: 1646210 [TBL] [Abstract][Full Text] [Related]
31. Molecular size of dermatan sulfate oligosaccharides required to bind and activate heparin cofactor II. Tollefsen DM; Peacock ME; Monafo WJ J Biol Chem; 1986 Jul; 261(19):8854-8. PubMed ID: 3755134 [TBL] [Abstract][Full Text] [Related]
32. The preferred pathway of glycosaminoglycan-accelerated inactivation of thrombin by heparin cofactor II. Verhamme IM; Bock PE; Jackson CM J Biol Chem; 2004 Mar; 279(11):9785-95. PubMed ID: 14701814 [TBL] [Abstract][Full Text] [Related]
33. Inhibitory effect of heparin cofactor II on thrombin-stimulated prostacyclin production by cultured vascular smooth muscle cells. Hayashi T; Kaji T; Hayakawa Y; Niiya K; Sakamoto M; Sakuragawa N Thromb Res; 1991 Nov; 64(3):321-30. PubMed ID: 1805447 [TBL] [Abstract][Full Text] [Related]
34. The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans. Van Deerlin VM; Tollefsen DM J Biol Chem; 1991 Oct; 266(30):20223-31. PubMed ID: 1939083 [TBL] [Abstract][Full Text] [Related]
35. Effects of antithrombin and heparin cofactor II levels on anticoagulation with Intimatan. Tanaka KA; Szlam F; Vinten-Johansen J; Cardin AD; Levy JH Thromb Haemost; 2005 Oct; 94(4):808-13. PubMed ID: 16270635 [TBL] [Abstract][Full Text] [Related]
36. Substitution of arginine for Leu444 in the reactive site of heparin cofactor II enhances the rate of thrombin inhibition. Derechin VM; Blinder MA; Tollefsen DM J Biol Chem; 1990 Apr; 265(10):5623-8. PubMed ID: 2138609 [TBL] [Abstract][Full Text] [Related]
37. Interaction of thrombin with heparin cofactor II and antithrombin III on prostacyclin production by cultured endothelial cells. Kaji T; Itoh F; Hayakawa Y; Oguma Y; Sakuragawa N Thromb Res; 1989 Oct; 56(1):99-107. PubMed ID: 2512688 [TBL] [Abstract][Full Text] [Related]
38. Effect of oligodeoxynucleotide thrombin aptamer on thrombin inhibition by heparin cofactor II and antithrombin. Holland CA; Henry AT; Whinna HC; Church FC FEBS Lett; 2000 Nov; 484(2):87-91. PubMed ID: 11068038 [TBL] [Abstract][Full Text] [Related]
39. Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a natural mixture of glycosaminoglycans. Cosmi B; Cini M; Legnani C; Pancani C; Calanni F; Coccheri S Thromb Res; 2003 Mar; 109(5-6):333-9. PubMed ID: 12818259 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of a thrombin anion-binding exosite-2 mutant by the glycosaminoglycan-dependent serpins protein C inhibitor and heparin cofactor II. Cooper ST; Rezaie AR; Esmon CT; Church FC Thromb Res; 2002 Jul; 107(1-2):67-73. PubMed ID: 12413592 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]